Weibo Zhang

Title: Weibo Zhang: Innovator in Chemical Drug Development

Introduction

Weibo Zhang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of chemical drugs, particularly in the development of compounds with anti-diabetic properties. With a total of 3 patents to his name, Zhang's work is recognized for its innovative approach and practical applications.

Latest Patents

One of Zhang's latest patents is titled "Compound with α-glucosidase inhibitory activity and application thereof." This invention focuses on a compound that exhibits strong anti-diabetic activity, providing a valuable alternative to existing treatments. The compound, specifically a 5-hydroxymethyl-8-methyl-2-(N-arylamino)-pyrano[2,3-c]pyridine-3-(N-aryl)-formamide series, demonstrates significant application value in the medical field.

Another notable patent is the "Method for modifying gliadin and application thereof." This method involves dissolving gliadin in a solvent to create a gliadin solution, followed by the addition of a proline endoprotease. The process results in a modified gliadin that maintains stability and uniform dispersion in water, even under high-temperature conditions and in the presence of sodium chloride.

Career Highlights

Weibo Zhang is affiliated with China Agricultural University, where he conducts research and development in the field of chemical drugs. His work has garnered attention for its potential impact on diabetes treatment and food science.

Collaborations

Zhang collaborates with several colleagues, including Yixuan Li and Pengjie Wang, who contribute to his research efforts and innovations.

Conclusion

Weibo Zhang's contributions to the field of chemical drugs highlight his innovative spirit and dedication to improving health outcomes. His patents reflect a commitment to advancing medical science and addressing critical health challenges.